In the current trading session, Arcutis Biotherapeutics Inc’s (ARQT) stock is trading at the price of $13.04, a fall of -3.41% over last night’s close. So, the stock is trading at a price that is -26.54% less than its 52-week high of $17.75 and 70.79% better than its 52-week low of $7.64.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ARQT’s SMA-200 is $12.61.
It is also essential to consider ARQT stock ratios like the price-to-sales ratio, which is 7.30 for the last year.ARQT’s price to book ratio for the most recent quarter was 10.89, resulting in an 7.82 price to cash per share for the period.
How does Arcutis Biotherapeutics Inc (ARQT) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Ownership Details
I will give a breakdown of the key shareholders in Arcutis Biotherapeutics Inc (ARQT). Recent figures show that the company’s insiders hold 1.94% of shares. A total of 325 institutional investors hold shares in the company, making 108.83% of its stock and 110.98% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Suvretta Capital Management, LLC holding total of 11.42 shares that make 9.58% of the company’s total number of shares and are currently priced at 148.96 million.
The securities firm Jennison Associates LLC holds 11.36 shares of ARQT, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 9.53% , and the holding percentage of shares is valued at 148.15 million.
An overview of Arcutis Biotherapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Arcutis Biotherapeutics Inc (ARQT) traded 1,844,481 shares per day, with a moving average of $13.77 and price change of -0.56. With the moving average of $13.95 and a price change of -3.53, about 2,105,548 shares changed hands on average over the past 50 days. Finally, ARQT’s 100-day average volume is 2,296,618 shares, alongside a moving average of $14.05 and a price change of -0.01.
